加味柴胡疏肝散治疗中风后抑郁症的临床研究

Clinical Study of Chaihu Shugan Powder in the Treatment of Depression After Apoplexy

[目的]探究加味柴胡疏肝散治疗中风后抑郁症的临床效果。[方法]将78例患者随机分为两组,两组患者的基础治疗相同都是缺血性脑中风的常规内科治疗及康复锻炼,除此外,治疗组患者应用加味柴胡疏肝散联合氟西汀治疗,对照组应用盐酸氟西汀胶囊治疗。[结果]治疗组39例,痊愈17例(43.59%),显效12例(30.77%),有效6例(15.38%),总有效率89.74%;对照组39例,治愈13例(33.33%),显效10例(25.64%),有效9例(23.08%),总有效率82.05%。两组疗效对比,P【0.05,差异有显著性,有统计学意义。[结论]加味柴胡疏肝散治疗中风后抑郁症的临床效果比盐酸氟西汀胶囊效果显著,更有利于患者的康复,值得临床应用。

[Objective]To investigate the clinical effect of Chaihu Shugan powder in the treatment of depression after apoplexy.[Methods]78 patients were randomly divided into two groups,they were received the same basic therapy involving Ischemic stroke treatment and routine rehabilitation exercise.In addition,the experimental group patients received modified Chaihushugansan combined fluoxetine treatment,the patients in control group received fluoxetine hydrochloride capsules treatment.[Results]The experimental group: 17 cases were cured(43.59%),effective in 6 cases(15.38%),the total effective rate was 89.74%;The control group: 13 cases were cured(33.33%),effective in 9 cases(23.08%),the total efficiency of 82.05%.There were significant differences between the two groups P< 0.05).[Conclusion]The clinical effect of Chaihu Shugan powder in the treatment of depression after apoplexy was better than fluoxetine hydrochloride capsule,it proved to be more conducive to the rehabilitation of patients,worthy of clinical application.